Metallothionein-III increases ADAM10 activity in association with furin, PC7, and PKCα during non-amyloidogenic processing

FEBS Letters

Volumn 588, Issue 14, 2014, Pages 2294-2300

  Park, Bong Hwan ^a   Kim, Hyung Gyun ^a   Jin, Sun Woo ^a   Song, Suk Gil ^b   Jeong, Hye Gwang ^a  

^a Chungnam National University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

A disintegrin and metalloproteinase 10; Furin; Metallothionein III; PKC ; Proprotein convertase7; Soluble APP

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FURIN; METALLOTHIONEIN III; PROPROTEIN CONVERTASE 7; PROTEIN KINASE C ALPHA; SERINE PROTEINASE; SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION;

A-DISINTEGRIN AND METALLOPROTEINASE 10; FURIN; METALLOTHIONEIN-III; PKCΑ; PROPROTEIN CONVERTASE7; SOLUBLE APPΑ;

ADAM PROTEINS; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL LINE, TUMOR; FURIN; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; PROTEIN KINASE C-ALPHA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBTILISINS;

EID: 84902655505     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.05.017     Document Type: Article

References (39)

1. S.S. Sisodia Beta-amyloid precursor protein cleavage by a membrane-bound protease Proc. Natl. Acad. Sci. U.S.A. 89 13 1992 6075 6079
2. C. Haass, E.H. Koo, A. Mellon, A.Y. Hung, and D.J. Selkoe Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments Nature 357 6378 1992 500 503
3. B. De Strooper, L. Umans, F. Van Leuven, and H. Van Den Berghe Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway J. Cell Biol. 121 2 1993 295 304
4. A.Y. Hung, C. Haass, R.M. Nitsch, W.Q. Qiu, M. Citron, R.J. Wurtman, J.H. Growdon, and D.J. Selkoe Activation of protein kinase C inhibits cellular production of the amyloid beta-protein J. Biol. Chem. 268 31 1993 22959 22962
5. S. Tsuji, H. Kobayashi, Y. Uchida, Y. Ihara, and T. Miyatake Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease EMBO J. 11 13 1992 4843 4850
6. I. Hozumi, T. Inuzuka, M. Hiraiwa, Y. Uchida, T. Anezaki, H. Ishiguro, H. Kobayashi, Y. Uda, T. Miyatake, and S. Tsuji Changes of growth inhibitory factor after stab wounds in rat brain Brain Res. 688 1-2 1995 143 148
7. H.G. Kim, Y.P. Hwang, E.H. Han, C.Y. Choi, C.Y. Yeo, J.Y. Kim, K.Y. Lee, and H.G. Jeong Metallothionein-III provides neuronal protection through activation of nuclear factor-kappaB via the TrkA/phosphatidylinositol-3 kinase/Akt signaling pathway Toxicol. Sci. 112 2 2009 435 449
8. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2 2001 741 766
9. T.E. Golde, C.B. Eckman, and S.G. Younkin Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease Biochim. Biophys. Acta 1502 1 2000 172 187
10. J.T. Huse, and R.W. Doms Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease Mol. Neurobiol. 22 1-3 2000 81 98
11. K. Sambamurti, N.H. Greig, and D.K. Lahiri Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease Neuromolecular Med. 1 1 2002 1 31
12. S. Funamoto, M. Morishima-Kawashima, Y. Tanimura, N. Hirotani, T.C. Saido, and Y. Ihara Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42 Biochemistry 43 42 2004 13532 13540
13. C. Pereira, P. Agostinho, P.I. Moreira, S.M. Cardoso, and C.R. Oliveira Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies Curr. Drug Targets CNS Neurol. Disord. 4 4 2005 383 403
14. N.M. Hooper, and A.J. Turner The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease Curr. Med. Chem. 9 11 2002 1107 1119
15. T.M. Allinson, E.T. Parkin, A.J. Turner, and N.M. Hooper ADAMs family members as amyloid precursor protein alpha-secretases J. Neurosci. Res. 74 3 2003 342 352
16. M. Asai, C. Hattori, B. Szabó, N. Sasagawa, K. Maruyama, S. Tanuma, and S. Ishiura Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase Biochem. Biophys. Res. Commun. 301 1 2003 231 235
17. E.R. Vardy, A.J. Catto, and N.M. Hooper Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease Trends Mol. Med. 11 10 2005 464 472
18. M. Arbel, I. Yacoby, and B. Solomon Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies Proc. Natl. Acad. Sci. U.S.A. 102 21 2005 7718 7723
19. P. Marambaud, H. Zhao, and P. Davies Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides J. Biol. Chem. 280 45 2005 37377 37382
20. A. Anders, S. Gilbert, W. Garten, R. Postina, and F. Fahrenholz Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases FASEB J. 15 10 2001 1837 1839
21. A. Basak, B. Ernst, D. Brewer, N.G. Seidah, J.S. Munzer, C. Lazure, and G.A. Lajoie Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1 J. Pept. Res. 49 6 1997 596 603
22. A. Basak Inhibitors of proprotein convertases J. Mol. Med. (Berl.) 83 11 2005 844 855
23. F. Checler Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease J. Neurochem. 65 4 1995 1431 1444
24. T. Kinouchi, H. Sorimachi, K. Maruyama, K. Mizuno, S. Ohno, S. Ishiura, and K. Suzuki Conventional protein kinase C (PKC)-alpha and novel PKC epsilon, but not -delta, increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts FEBS Lett. 364 2 1995 203 206
25. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 5580 2002 353 356
26. K. Rezai-Zadeh, D. Shytle, N. Sun, T. Mori, H. Hou, D. Jeanniton, J. Ehrhart, K. Townsend, J. Zeng, D. Morgan, J. Hardy, T. Town, and J. Tan Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J. Neurosci. 25 38 2005 8807 8814
27. D.F. Obregon, K. Rezai-Zadeh, Y. Bai, N. Sun, H. Hou, J. Ehrhart, J. Zeng, T. Mori, G.W. Arendash, D. Shytle, T. Town, and J. Tan ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein J. Biol. Chem. 281 24 2006 16419 16427
28. Y. Manso, J. Carrasco, G. Comes, G. Meloni, P.A. Adlard, A.l. Bush, M. Vašák, and J. Hidalgo Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease Cell. Mol. Life Sci. 69 21 2012 3683 3700
29. J.D. Buxbaum, E.H. Koo, and P. Greengard Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide Proc. Natl. Acad. Sci. U.S.A. 90 19 1993 9195 9198
30. D. Gabuzda, J. Busciglio, and B.A. Yankner Inhibition of beta-amyloid production by activation of protein kinase C J. Neurochem. 61 6 1993 2326 2329
31. J.S. Jacobsen, M.A. Spruyt, A.M. Brown, S.R. Sahasrabudhe, A.J. Blume, M.P. Vitek, H.A. Muenkel, and J. Sonnenberg-Reines The release of Alzheimer's disease beta amyloid peptide is reduced by phorbol treatment J. Biol. Chem. 269 11 1994 8376 8382
32. L.M. Bekris, F. Lutz, G. Li, D.R. Galasko, M.R. Farlow, J.F. Quinn, J.A. Kaye, J.B. Leverenz, D.W. Tsuang, T.J. Montine, E.R. Peskind, and C.E. Yu ADAM10 expression and promoter haplotype in Alzheimer's disease Neurobiol. Aging 33 9 2012 2229.e1 2229.e9
33. H.Q. Yang, Z.K. Sun, M.W. Ba, J. Xu, and Y. Xing Involvement of protein trafficking in deprenyl-induced alpha-secretase activity regulation in PC12 cells Eur. J. Pharmacol. 610 1-3 2009 37 41
34. C. Lanni, M. Mazzucchelli, E. Porrello, S. Govoni, and M. Racchi Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein Eur. J. Biochem. 271 14 2004 3068 3075
35. S.W. Yeon, M.W. Jung, M.J. Ha, S.U. Kim, K. Huh, M.J. Savage, E. Masliah, and I. Mook-Jung Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alpha-secretase-derived secreted form of amyloid precursor protein Biochem. Biophys. Res. Commun. 280 3 2001 782 787
36. A.K. Olsson, K. Vadhammar, and E. Nånberg Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells Exp. Cell Res. 256 2 2000 454 467
37. C. Gil, I. Chaïb-Oukadour, P. Pelliccioni, and J. Aguilera Activation of signal transduction pathways involving trkA, PLCgamma-1, PKC isoforms and ERK-1/2 by tetanus toxin FEBS Lett. 481 2 2000 177 182
38. S. Rossner, K. Mendla, R. Schliebs, and V. Bigl Protein kinase C alpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo Eur. J. Neurosci. 13 8 2001 1644 1648
39. 7metallothionein-3: evidence for an additional zinc binding site Biochemistry 48 24 2009 5700 5707